Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells.
Kolben T, Mannewitz M, Perleberg C, Schnell K, Anz D, Hahn L, Meister S, Schmoeckel E, Burges A, Czogalla B, Hester A, Mahner S, Kessler M, Jeschke U, Corradini S, Trillsch F, Beyer S. Kolben T, et al. Among authors: trillsch f. Cell Oncol (Dordr). 2022 Dec;45(6):1171-1185. doi: 10.1007/s13402-022-00708-2. Epub 2022 Sep 13. Cell Oncol (Dordr). 2022. PMID: 36098901 Free PMC article.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Clinical management of primary vulvar cancer.
Woelber L, Kock L, Gieseking F, Petersen C, Trillsch F, Choschzick M, Jaenicke F, Mahner S. Woelber L, et al. Among authors: trillsch f. Eur J Cancer. 2011 Oct;47(15):2315-21. doi: 10.1016/j.ejca.2011.06.007. Epub 2011 Jul 4. Eur J Cancer. 2011. PMID: 21733674 Review.
Lost in effusion.
Trillsch F, Aberle J, Regier M, Choschzick M, Mahner S. Trillsch F, et al. Lancet. 2012 Aug 11;380(9841):620. doi: 10.1016/S0140-6736(12)60323-7. Lancet. 2012. PMID: 22883511 No abstract available.
Adjuvant therapy in node-positive vulvar cancer.
Mahner S, Trillsch F, Kock L, Rohsbach D, Petersen C, Kruell A, Harter P, Jaenicke F, Woelber L. Mahner S, et al. Among authors: trillsch f. Expert Rev Anticancer Ther. 2013 Jul;13(7):839-44. doi: 10.1586/14737140.2013.811063. Expert Rev Anticancer Ther. 2013. PMID: 23875662 Review.
The prognostic significance of Jun transcription factors in ovarian cancer.
Eckhoff K, Flurschütz R, Trillsch F, Mahner S, Jänicke F, Milde-Langosch K. Eckhoff K, et al. Among authors: trillsch f. J Cancer Res Clin Oncol. 2013 Oct;139(10):1673-80. doi: 10.1007/s00432-013-1489-y. Epub 2013 Aug 13. J Cancer Res Clin Oncol. 2013. PMID: 23942796
Clinical management of epithelial ovarian cancer during pregnancy.
Grimm D, Woelber L, Trillsch F, Keller-v Amsberg G, Mahner S. Grimm D, et al. Among authors: trillsch f. Eur J Cancer. 2014 Mar;50(5):963-71. doi: 10.1016/j.ejca.2013.12.020. Epub 2014 Jan 23. Eur J Cancer. 2014. PMID: 24462638 Review.
113 results